The Food and Drug Administration approved in February 2004 the use of pemetrexed brand named Alimta for the treatment of malignant pleural
Mesothelioma has reacted positively to certain treatments using immunotherapy. …
XHTML: You can use these tags: <a href="" title=""> <abbr call=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>
Treatment. The survival time after diagnosis is around 6 to 12 months. The move of malignant cells to the underlying create from raw material and other organs in the pleural cavity the pleural cavity encouraging local metastasis by exfoliated cells the long inactive period between asbestos exposure and development of the disease are among the chief reasons for the malignancy not responding to treatments. Surgery for mesothelioma may be performed to ameliorate hurt and discomfort caused by the tumor or to aid the patient. Palliative surgery is typically done in cases where the tumor has already spread beyond the mesothelium and is difficult to completely remove or in cases where the patient is too ill to allow a more extensive operation. Curative surgery is offered when the patient is in good health and the tumor is thought to be localized and can be completely removed. Mesothelioma is highly resistant to radiation therapy and chemotherapy. These treatments are mainly used ameliorate symptoms due to tumor metastasis. The Food and medicate Administration approved in February 2004 the use of pemetrexed brand named Alimta for the treatment of malignant pleural mesothelioma. Mesothelioma has reacted positively to certain treatments using immunotherapy. The attempt to boost immune response using intrapleural inoculation of Bacillus Calmette-Guérin (BCG) had not effect in Mesothelioma treatment and the patients who underwent this treatment had several side effects. Immunotherapy involving interferon alpha has been able to reduce tumor by 50% in certain patients. The side effects of this treatment were minimal. Heated intraoperative intraperitoneal chemotherapy a procedure developed by Paul Sugarbaker at the Washington Cancer Institute is a breakthrough in Mesothelioma treatment. He is able to shift a larger be of tumor by the direct administration of a chemotherapy agent in the abdomen. In this treatment high concentrations of selected drugs can be administrated into the abdominal and pelvic surfaces. The fluid used is perfused for 60 to 120 minutes and then drained out. When the medicate is heated to 40 to 48 degree Celsius it increases the penetration of drugs into tissues. The heating also damages the malignant cells. New treatment approaches such as gene therapy are under clinical trials. Age contributing health problems or advanced state of disease may make aggressive treatment impossible. In these cases palliative compassionate which treats the symptoms is ideal.
XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote have in mind=""> <code> <em> <i> <strike> <strong>
Forex Groups - Tips on Trading
Related article:
http://www.peterjonesweb.com/alimtatreatment/mesothelioma/mesothelioma-treatment-introduction
comments | Add comment | Report as Spam
|